Cellectis SA (CLLS)
1.88
+0.02
(+1.08%)
USD |
NASDAQ |
Nov 22, 16:00
1.88
0.00 (0.00%)
After-Hours: 17:51
Cellectis Shareholders Equity (Quarterly): 129.42M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 129.42M |
June 30, 2024 | 148.61M |
March 31, 2024 | 90.57M |
December 31, 2023 | 84.70M |
September 30, 2023 | 76.12M |
June 30, 2023 | 96.56M |
March 31, 2023 | 113.74M |
December 31, 2022 | 117.97M |
September 30, 2022 | 136.64M |
June 30, 2022 | 168.93M |
March 31, 2022 | 191.04M |
December 31, 2021 | 221.29M |
September 30, 2021 | 237.97M |
June 30, 2021 | 275.86M |
March 31, 2021 | 261.93M |
December 31, 2020 | 283.80M |
September 30, 2020 | 290.37M |
June 30, 2020 | 307.61M |
March 31, 2020 | 331.84M |
December 31, 2019 | 315.12M |
September 30, 2019 | 340.64M |
June 30, 2019 | 363.82M |
March 31, 2019 | 391.15M |
December 31, 2018 | 409.30M |
September 30, 2018 | 430.65M |
Date | Value |
---|---|
June 30, 2018 | 447.73M |
March 31, 2018 | 255.32M |
December 31, 2017 | 264.87M |
September 30, 2017 | 282.40M |
June 30, 2017 | 267.87M |
March 31, 2017 | 269.24M |
December 31, 2016 | 272.80M |
September 30, 2016 | 284.50M |
June 30, 2016 | 283.49M |
March 31, 2016 | 277.78M |
December 31, 2015 | 287.42M |
September 30, 2015 | 269.27M |
June 30, 2015 | 272.61M |
March 31, 2015 | 283.59M |
December 31, 2014 | 73.92M |
June 30, 2014 | 28.13M |
December 31, 2013 | 3.784M |
June 30, 2013 | 53.89M |
June 30, 2013 | 53.89M |
December 31, 2012 | 69.90M |
June 30, 2012 | 87.63M |
June 30, 2012 | 87.63M |
December 31, 2011 | 37.02M |
December 31, 2010 | 49.85M |
June 30, 2010 | 59.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
76.12M
Minimum
Sep 2023
331.84M
Maximum
Mar 2020
194.00M
Average
179.99M
Median
Shareholders Equity (Quarterly) Benchmarks
Edap TMS SA | 47.63M |
DBV Technologies SA | 54.03M |
Genfit SA | 75.11M |
Adaptimmune Therapeutics PLC | 79.99M |
Akari Therapeutics PLC | -6.694M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 395.88M |
Total Liabilities (Quarterly) | 266.45M |
Debt to Equity Ratio | 0.3579 |
Current Ratio | 1.777 |
Net Debt Paydown Yield | -1.21% |